Optimized expression and purification of adipose triglyceride lipase improved hydrolytic and transacylation activities in vitro.


Journal

The Journal of biological chemistry
ISSN: 1083-351X
Titre abrégé: J Biol Chem
Pays: United States
ID NLM: 2985121R

Informations de publication

Date de publication:
10 2021
Historique:
received: 17 04 2021
revised: 06 09 2021
accepted: 15 09 2021
pubmed: 21 9 2021
medline: 24 11 2021
entrez: 20 9 2021
Statut: ppublish

Résumé

Adipose triglyceride lipase (ATGL) plays a key role in intracellular lipolysis, the mobilization of stored triacylglycerol. This work provides an important basis for generating reproducible and detailed data on the hydrolytic and transacylation activities of ATGL. We generated full-length and C-terminally truncated ATGL variants fused with various affinity tags and analyzed their expression in different hosts, namely E.coli, the insect cell line Sf9, and the mammalian cell line human embryonic kidney 293T. Based on this screen, we expressed a fusion protein of ATGL covering residues M1-D288 flanked with N-terminal and C-terminal purification tags. Using these fusions, we identified key steps in expression and purification protocols, including production in the E. coli strain ArcticExpress (DE3) and removal of copurified chaperones. The resulting purified ATGL variant demonstrated improved lipolytic activity compared with previously published data, and it could be stimulated by the coactivator protein comparative gene identification-58 and inhibited by the protein G0/G1 switch protein 2. Shock freezing and storage did not affect the basal activity but reduced coactivation of ATGL by comparative gene identification 58. In vitro, the truncated ATGL variant demonstrated acyl-CoA-independent transacylation activity when diacylglycerol was offered as substrate, resulting in the formation of fatty acid as well as triacylglycerol and monoacylglycerol. However, the ATGL variant showed neither hydrolytic activity nor transacylation activity upon offering of monoacylglycerol as substrate. To understand the role of ATGL in different physiological contexts, it is critical for future studies to identify all its different functions and to determine under what conditions these activities occur.

Identifiants

pubmed: 34543623
pii: S0021-9258(21)01008-5
doi: 10.1016/j.jbc.2021.101206
pmc: PMC8506970
pii:
doi:

Substances chimiques

Recombinant Proteins 0
Lipase EC 3.1.1.3
PNPLA2 protein, human EC 3.1.1.3
PNPLA2 protein, mouse EC 3.1.1.3

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

101206

Subventions

Organisme : Medical Research Council
ID : MR/K018779/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/K018779/1
Pays : United Kingdom

Informations de copyright

Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Conflict of interest The authors declare that they have no conflicts of interest with the contents of this article.

Auteurs

Natalia Kulminskaya (N)

Institute of Molecular Biosciences, University of Graz, Graz, Austria.

Claudia Radler (C)

Institute of Molecular Biosciences, University of Graz, Graz, Austria.

Roland Viertlmayr (R)

Institute of Molecular Biosciences, University of Graz, Graz, Austria.

Christoph Heier (C)

Institute of Molecular Biosciences, University of Graz, Graz, Austria.

Peter Hofer (P)

Institute of Molecular Biosciences, University of Graz, Graz, Austria.

Mariana Colaço-Gaspar (M)

Institute of Molecular Biosciences, University of Graz, Graz, Austria.

Raymond J Owens (RJ)

Division of Structural Biology, The Welcome Centre for Human Genetics, University of Oxford, Oxford, UK; Protein Production UK, Research Complex at Harwell, Didcot, UK.

Robert Zimmermann (R)

Institute of Molecular Biosciences, University of Graz, Graz, Austria; BioTechMed, Graz, Austria; BioHealth Field of Excellence, University of Graz, Graz, Austria.

Renate Schreiber (R)

Institute of Molecular Biosciences, University of Graz, Graz, Austria.

Rudolf Zechner (R)

Institute of Molecular Biosciences, University of Graz, Graz, Austria; BioTechMed, Graz, Austria; BioHealth Field of Excellence, University of Graz, Graz, Austria.

Monika Oberer (M)

Institute of Molecular Biosciences, University of Graz, Graz, Austria; BioTechMed, Graz, Austria; BioHealth Field of Excellence, University of Graz, Graz, Austria. Electronic address: m.oberer@uni-graz.at.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH